Table 1.
miRNA | Functional Assay | Region | Disease Relevance/Context | Ref. |
---|---|---|---|---|
miR-181a | Gof/Lof | 3′-UTR | Acute Myeloid Leukemia | [61] |
miR-7-5p | Gof/Lof; Reporter assay | 3′-UTR | Small cell lung cancer | [62] |
miR-379-5p | Luciferase Reporter assay | 3′-UTR | Premature ovarian insufficiency | [63] |
miR-103a-2-5 pmiR-585-5p |
Luciferase Reporter assay | ORF | Oxidative stress, Hypertension | [64] |
miR-335 | Luciferase Reporter assay | 3′-UTR | Small cell lung cancer | [65] |
miR-520 | Luciferase Reporter assay | 3′-UTR | Recurrent spontaneous abortion | [66] |
miR-223 | Gof/Lof; Reporter assay | 3′-UTR | Pulmonary arterial hypertension | [67] |
miR-489 | Luciferase Reporter assay | 3′-UTR | Ischemic kidney injury | [68] |
Let-7a | Luciferase Reporter assay | 3′-UTR | HER2-overexpressing Breast cancer | [69] |
miR-149 | Luciferase Reporter assay | 3′-UTR | Skeletal muscle metabolism | [16] |
miR-577 | Luciferase Reporter assay | 3′-UTR | Myocardial infarction | [70] |
miR-221-3p | Luciferase Reporter assay | 3′-UTR | Triple negative Breast cancer | [61] |
miR-124 | Gof/Lof; Reporter assay, RNA-pulldown |
3′-UTR | Drug (cocaine) abuse | [52] |
miR-125b | Gof/Lof; Reporter assay, RNA-pull-down |
3′-UTR | Drug (cocaine) abuse; Regulation of HIV integration |
[53,71] |
Abbreviations used: Gof/Lof, gain-of-function/loss-of-function; 3′-UTR, 3′-untranslated region; ORF, open reading frame.